Paul Napoli Appointed to Leadership Role in the New York Opioid Cost Recovery Litigation
02 oct. 2017 07h30 HE
|
Napoli Shkolnik PLLC
NEW YORK, NY--(Marketwired - October 02, 2017) - Napoli Shkolnik PLLC is proud to announce that Paul Napoli was named Co-Lead Counsel in the New York Opioid Cost Recovery Litigation by Judge Jerry...
Portland Taps Napoli Shkolnik To Join Nationwide Opioid Lawsuit
20 sept. 2017 07h30 HE
|
Napoli Shkolnik PLLC
NEW YORK, NY--(Marketwired - September 20, 2017) - Maine's largest city selected the New York City-based litigation firm to help offset the "massive damages" that the heroin addiction epidemic has...
Mora County Files Lawsuit Seeking Damages Against Manufacturers and Distributors of Opioids
31 août 2017 15h20 HE
|
Napoli Shkolnik PLLC
MORA, NM--(Marketwired - August 31, 2017) - Mora County has become the first New Mexico governmental entity to seek damages against the manufacturers and distributors of opioid painkillers.Mora County...
UPDATE - Schuyler County Joins Growing List of New York Counties Against Opioids
16 août 2017 16h43 HE
|
Napoli Shkolnik PLLC
WATKINS GLEN, NY--(Marketwired - August 16, 2017) - Schuyler County has become the latest New York State county to take action against the manufacturers and distributors of opioid pain killers.The...
Schuyler County Joins Growing List of New York Counties Against Opioids
16 août 2017 15h27 HE
|
Napoli Shkolnik PLLC
WATKINS GLEN, NY--(Marketwired - August 16, 2017) - Schuyler County has become the latest New York State county to take action against the manufacturers and distributors of opioid pain killers.The...
Napoli Shkolnik PLLC Files Lawsuit Against Opioid Manufacturers and Distributors on Behalf of the City of Parma, Ohio
11 août 2017 14h52 HE
|
Napoli Shkolnik PLLC
NEW YORK, NY--(Marketwired - August 11, 2017) - The City of Parma, Ohio has become the latest Ohio city to take action against the manufacturers and distributors of opioid pain medications for their...
Issue Brief Explores the Many Facets of Opioid Abuse
14 sept. 2016 07h33 HE
|
The Center for Health Affairs
CLEVELAND, Sept. 14, 2016 (GLOBE NEWSWIRE) -- The Center for Health Affairs' August 2016 Issue Brief, A Growing Epidemic: Battling Opioid Abuse in Ohio, explores the many facets of the opioid abuse...
Lightlake Therapeutics Inc.Announces Adapt Pharma Limited to Offer All U.S. High Schools a Free Narcan® (Naloxone Hydrochloride) Nasal Spray and Fund School-Based Opioid Overdose Education
27 janv. 2016 09h00 HE
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Jan. 27, 2016 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Facilitates NARCAN® (Naloxone Hydrochloride) Nasal Spray Access to 62,000 State and Local Public Entities
19 janv. 2016 09h00 HE
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...
Lightlake Therapeutics Inc. Receives Milestone Payment for U.S. Food and Drug Administration Approval of NARCAN(R) (Naloxone Hydrochloride) Nasal Spray
15 déc. 2015 09h00 HE
|
Opiant Pharmaceuticals, Inc.
NEW YORK, Dec. 15, 2015 (GLOBE NEWSWIRE) -- Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use,...